Clinical Trials Arena March 8, 2024
GlobalData Healthcare

The US joins more than 100 countries where the contraceptive pill is available without a prescription.

Manufacturer Perrigo announced on 4 March that Opill (norgestrel), the first daily over-the-counter birth control pill, will be available in the US in the next few weeks.

Opill has been available by prescription for nearly 50 years, but last year, the Food and Drug Administration (FDA) approved Opill as a non-prescription oral contraceptive in the US. The cost of a one-month supply will be $19.99.

Opill is a progestin-only birth control pill, which is considered safer compared to other contraceptive drugs containing estrogen and progestin. Opill works by raising progestin levels, which leads to the thickening of the mucus in the cervix, preventing sperm...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Bridging the Gap: Pharmacists' Role in Advancing Pharmacogenomic Testing Standards

Share This Article